# Equity Research Run Manifest
## Claude Sonnet 4.6 | April 16, 2026

---

## Run Metadata

| Field | Value |
|-------|-------|
| **Run ID** | claude-sonnet-4-6-2026-04-16 |
| **Model** | Claude Sonnet 4.6 |
| **Execution Date** | 2026-04-16 |
| **Execution Time (EST)** | Pre-market through market close (scheduled) |
| **Status** | **REVIEW_ONLY** (locked) |
| **Governance** | Committee REJECT for live trading |
| **Stage Reached** | RISK_REVIEW (blocking issues documented) |

---

## Run Classification

### Regime & Market Context
- **Regime**: BULL (medium confidence)
- **Baseline Regime** (March 16): HIGH_VOL + RATE_SHOCK
- **Regime Shift**: De-escalation of volatility, QQQ strength, financial sector validation
- **VIX (March 16)**: 24.29 | **Expected Range (April 16)**: 16–20
- **10Y UST (March 16)**: +32bps spike | **Status (April 16)**: Stabilizing

### Market Summary (April 16)
- **SPY**: +0.04% | **QQQ**: +0.68%
- **NVDA**: +2.87% | **AVGO**: +4.20% | **META**: +1.37%
- **Key Data**: JPM Q1 beat + BAC earnings confirmation → Financial stress absent
- **April 29 Risk**: META, GEV, MSFT earnings cluster

---

## Baseline Reference: Claude Opus 4.6 | March 16, 2026

### March 16 Portfolio Recommendation (GO)
| Ticker | Allocation | Score (100-scale) | Rationale |
|--------|-----------|------------------|-----------|
| NVDA | 5.0% | 83 | AI leadership, supply dominance |
| AVGO | 4.5% | 78 | Fabless strength, broad exposure |
| GEV | 4.0% | 77 | Infrastructure AI thesis |
| GS | 4.0% | 71 | Financial large-cap strength |
| AMD | 3.5% | 71 | Competitive uptick, process node gains |
| LRCX | 3.0% | 71 | Semi equipment demand thesis |
| INTC | 3.0% | 68 | Process node risk, valuation trapped |
| MU | 2.5% | 70 | Memory demand, commodity pressure |
| **Cash** | 70.5% | — | Rate shock + vol cushion |

### March → April Performance (Known Prices)
| Ticker | March 16 | April 16 | Return | Status |
|--------|----------|----------|--------|--------|
| **AVGO** | $324.92 | $396.72 | **+22.0%** | ✅✅ Strong outperformance |
| **META** | $627.45 | $671.58 | **+7.0%** | ✅ NOT in March portfolio |
| **GEV** | $827.37 | $841.27 | **+1.7%** | ✅ Modest gain |
| **NVDA** | — | — | **Positive** | ✅ Positive but less directional |
| **GS** | — | — | **Q1 beat** | ✅ Large-cap financial strength |
| **INTC** | — | — | **Underperform** | ❌ Execution issues persist |
| **AMD** | — | — | **Underperform** | ❌ Lagged AI leaders |
| **LRCX** | — | — | **Underperform** | ❌ Equipment lagged direct plays |
| **MU** | — | — | **Mixed** | ❌ Volatility + commodity pressure |

### Key Findings
1. **AVGO** was March's standout winner (+22%), validating fabless broad-exposure thesis
2. **META** (+7%) was NOT in March portfolio — represents identified miss
3. **GEV** modest but positive, validating infrastructure AI thesis
4. **INTC, AMD, LRCX, MU** all underperformed → explicit downgrade candidates April 16

---

## April 16 Run: Carry-Forward & Downgrade Summary

### What Worked (March → April Validated)
- ✅ **AVGO thesis**: Fabless strength + AI infrastructure demand → +22% return
- ✅ **GEV thesis**: Infrastructure AI, cloud capex cycles → +1.7% gain
- ✅ **NVDA**: AI leadership persists (positive return, lower volatility)
- ✅ **Financial sector**: JPM/BAC earnings beat → GS positioning validated
- ✅ **Regime shift**: HIGH_VOL+RATE_SHOCK → BULL improves broad positioning

### What Failed (March → April Underperformed)
- ❌ **INTC**: Execution missteps, process node delays → Explicit downgrade
- ❌ **AMD**: Lagged AI infrastructure leaders (Nvidia, Broadcom) → Explicit downgrade
- ❌ **LRCX**: Semi equipment underperformed direct AI plays → Explicit downgrade
- ❌ **MU**: Memory commodity pressure + post-earnings volatility → Explicit downgrade

### April 16 Recommended Action
- **Carry Forward**: AVGO, GEV (validated winners) + NVDA (leader stability)
- **Add**: META (identified miss, +7% YTD, April 29 earnings catalyst)
- **Downgrade**: INTC, AMD, LRCX, MU (all underperformed relative universe)

---

## Universe & Data Coverage

### Sampled Universe
- **Total Names Evaluated**: 16
- **Sample Passes** (recommended): 5
- **Near-Misses / Rejects**: 11
- **Universe Source**: Filtered for mega-cap liquidity + AI exposure + earnings cluster risk

### Data Quality Status
- **Quote Timestamps**: Asynchronous (end-of-day, 15-min delay)
- **Earnings Dates**: Validated for April 29 cluster (META, GEV, MSFT)
- **Factor Coverage**: ✅ Valuation, ✅ Quality, ✅ Growth, ✅ Momentum, ✅ Macro fit
- **Risk Feeds**: ⚠️ No full-universe portfolio risk validated
- **Constraints**: 100% portfolio, no short, $1B+ market cap, US-listed

### Data Quality Multipliers
- All 16 names: DQ = 0.95 (asynchronous quote timestamps)
- Factor-level adjustments: ±0.05 per incomplete metric

---

## Run State & Governance

### State Machine Position
```
PRECHECK ✅ → REFLECTION ✅ → DATA_OK ✅ → SCORED ✅ → 
PORTFOLIO_DRAFT ✅ → RISK_REVIEW ⛔ (REJECT locked) → PUBLISHED ❌
```

### Committee Decision (Risk Review)
| Decision | Reason | Blocking Issues |
|----------|--------|-----------------|
| **REVIEW_ONLY** | 4 blocking issues identified | See 07_risk_review.md |
| **NOT GO** | Portfolio concentration + earnings cluster risk | Constraint violations |
| **Maintain REVIEW** | Thesis quality high, execution risk elevated | Data + governance gaps |

### Blocking Issues (7_risk_review.md)
1. **Portfolio Concentration**: 5-stock concentration at 100% → VaR blow-through risk
2. **April 29 Earnings Cluster**: META, GEV, MSFT all report same week → Single event risk
3. **Data Validation Gap**: No full-universe risk feed; asynchronous quotes impede real-time rebalance
4. **Governance**: REVIEW_ONLY lock prevents live execution

---

## Output File Map

| File | Purpose | Status |
|------|---------|--------|
| `00_run_manifest.md` | Run metadata, baseline ref, MoM performance | ✅ You are here |
| `01_preflight.md` | Data coverage checks, REVIEW_ONLY lock rationale | ✅ |
| `02_regime_and_data.md` | Regime BULL, macro context, April 16 market | ✅ |
| `03_universe_summary.md` | 16-name sample, 5 passes, 11 rejects | ✅ |
| `04_factor_scores.md` | 1-5 factor scores, adjusted, DQ multipliers | ✅ |
| `05_top_candidates.md` | 5 recommended with thesis, risk, near-misses | ✅ |
| `06_portfolio_proposal.md` | Paper-trade basket, constraint violations | ✅ |
| `07_risk_review.md` | Committee REJECT, 4 blocking issues | ✅ |
| `08_final_report.md` | Executive summary, MoM reflection, REVIEW_ONLY | ✅ |
| `09_midday_monitor.md` | 12:15 ET checkpoint template | ✅ |
| `10_preclose_check.md` | 15:45 ET checkpoint template | ✅ |
| `11_close_log.md` | 16:20 ET placeholder | ✅ |
| `12_evolution_log.md` | Reflection on process, proposed improvements | ✅ |

---

## Key Dates & Deadlines

| Date | Event | Impact |
|------|-------|--------|
| 2026-04-16 | **Today** — Run execution, REVIEW_ONLY lock | Governance active |
| 2026-04-29 | **Earnings cluster**: META, GEV, MSFT | ⚠️ Blocking issue #2 |
| 2026-05-01 | **Typical rebalance window** | Next decision point |

---

## Executive Summary

**Claude Sonnet 4.6** executed the equity research framework on April 16, 2026 under a **BULL regime** (medium confidence). The run validates the March 16 AVGO/GEV/NVDA thesis while identifying META (+7%) as a missed opportunity. However, **4 blocking issues** in risk review (concentration, earnings cluster, data gaps, governance) force a **REVIEW_ONLY** classification with no live trading authorization.

The framework produced a **5-stock portfolio** (AVGO 22%, META 20%, NVDA 20%, GEV 19%, MSFT 19%) with strong individual theses but insufficient risk controls for live execution. The next evolution should formalize a dedicated **02_reflection.md** artifact to systematize MoM backtesting and improve downgrade signals.

**Status**: REVIEW_ONLY | **Next Review**: 2026-05-01

---

*Run completed by Claude Sonnet 4.6 on 2026-04-16. Generated for equity research and backtesting purposes.*
